The wheeling and dealing isn’t done for Chesterbrook specialty biopharmaceutical firm Auxilium. Fresh off a $345 million merger with a Canadian ophthalmology biotech company, it has lured away the senior vice president of finance from Endo in Malvern.
Andrew Saik will become Auxilium’s new chief financial officer on Aug. 18, according to a Philadelphia Business Journal report.
Read more about the new hire and who he is replacing in the Philadelphia Business Journal here.
